BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 22705006)

  • 1. A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches.
    Seki E; Brenner DA; Karin M
    Gastroenterology; 2012 Aug; 143(2):307-20. PubMed ID: 22705006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into the role and mechanism of c-Jun-N-terminal kinase signaling in the pathobiology of liver diseases.
    Win S; Than TA; Zhang J; Oo C; Min RWM; Kaplowitz N
    Hepatology; 2018 May; 67(5):2013-2024. PubMed ID: 29194686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of apoptosis signal-regulating kinase 1 attenuates acetaminophen-induced liver injury by inhibiting c-Jun N-terminal kinase activation.
    Nakagawa H; Maeda S; Hikiba Y; Ohmae T; Shibata W; Yanai A; Sakamoto K; Ogura K; Noguchi T; Karin M; Ichijo H; Omata M
    Gastroenterology; 2008 Oct; 135(4):1311-21. PubMed ID: 18700144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antcin H Protects Against Acute Liver Injury Through Disruption of the Interaction of c-Jun-N-Terminal Kinase with Mitochondria.
    Huo Y; Win S; Than TA; Yin S; Ye M; Hu H; Kaplowitz N
    Antioxid Redox Signal; 2017 Feb; 26(5):207-220. PubMed ID: 27596680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitor of apoptosis signal-regulating kinase 1 protects against acetaminophen-induced liver injury.
    Xie Y; Ramachandran A; Breckenridge DG; Liles JT; Lebofsky M; Farhood A; Jaeschke H
    Toxicol Appl Pharmacol; 2015 Jul; 286(1):1-9. PubMed ID: 25818599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of c-jun (NH2) terminal kinase in paracetamol- induced acute liver failure.
    Henderson NC; Pollock KJ; Frew J; Mackinnon AC; Flavell RA; Davis RJ; Sethi T; Simpson KJ
    Gut; 2007 Jul; 56(7):982-90. PubMed ID: 17185352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress kinases in the development of liver steatosis and hepatocellular carcinoma.
    Cicuéndez B; Ruiz-Garrido I; Mora A; Sabio G
    Mol Metab; 2021 Aug; 50():101190. PubMed ID: 33588102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the effects of CYP2E1-induced oxidative stress by JNK signaling.
    Schattenberg JM; Czaja MJ
    Redox Biol; 2014; 3():7-15. PubMed ID: 25462060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen peroxide inducible clone-5 mediates reactive oxygen species signaling for hepatocellular carcinoma progression.
    Wu JR; Hu CT; You RI; Pan SM; Cheng CC; Lee MC; Wu CC; Chang YJ; Lin SC; Chen CS; Lin TY; Wu WS
    Oncotarget; 2015 Oct; 6(32):32526-44. PubMed ID: 26416447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JNK regulation of hepatic manifestations of the metabolic syndrome.
    Czaja MJ
    Trends Endocrinol Metab; 2010 Dec; 21(12):707-13. PubMed ID: 20888782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance.
    Karin M; Gallagher E
    IUBMB Life; 2005; 57(4-5):283-95. PubMed ID: 16036612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor for activated C kinase 1 promotes hepatocellular carcinoma growth by enhancing mitogen-activated protein kinase kinase 7 activity.
    Guo Y; Wang W; Wang J; Feng J; Wang Q; Jin J; Lv M; Li X; Li Y; Ma Y; Shen B; Zhang J
    Hepatology; 2013 Jan; 57(1):140-51. PubMed ID: 22903704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decoding cell death signals in liver inflammation.
    Brenner C; Galluzzi L; Kepp O; Kroemer G
    J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing glycogen synthase kinase-3beta inhibits acetaminophen hepatotoxicity and attenuates JNK activation and loss of glutamate cysteine ligase and myeloid cell leukemia sequence 1.
    Shinohara M; Ybanez MD; Win S; Than TA; Jain S; Gaarde WA; Han D; Kaplowitz N
    J Biol Chem; 2010 Mar; 285(11):8244-55. PubMed ID: 20061376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyphenols reported to shift APAP-induced changes in MAPK signaling and toxicity outcomes.
    Nguyen NU; Stamper BD
    Chem Biol Interact; 2017 Nov; 277():129-136. PubMed ID: 28918124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low Dose Acetaminophen Induces Reversible Mitochondrial Dysfunction Associated with Transient c-Jun N-Terminal Kinase Activation in Mouse Liver.
    Hu J; Ramshesh VK; McGill MR; Jaeschke H; Lemasters JJ
    Toxicol Sci; 2016 Mar; 150(1):204-15. PubMed ID: 26721299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Jun NH
    Chen Y; Liu K; Zhang J; Hai Y; Wang P; Wang H; Liu Q; Wong CCL; Yao J; Gao Y; Liao Y; Tang X; Wang XJ
    Hepatology; 2020 May; 71(5):1787-1801. PubMed ID: 31945188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sestrin Proteins Protect Against Lipotoxicity-Induced Oxidative Stress in the Liver via Suppression of C-Jun N-Terminal Kinases.
    Fang Z; Kim HG; Huang M; Chowdhury K; Li MO; Liangpunsakul S; Dong XC
    Cell Mol Gastroenterol Hepatol; 2021; 12(3):921-942. PubMed ID: 33962074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of MKK7-JNK by the TOR signaling pathway regulator-like protein contributes to resistance of HCC cells to TRAIL-induced apoptosis.
    Song IS; Jun SY; Na HJ; Kim HT; Jung SY; Ha GH; Park YH; Long LZ; Yu DY; Kim JM; Kim JH; Ko JH; Kim CH; Kim NS
    Gastroenterology; 2012 Nov; 143(5):1341-1351. PubMed ID: 22841785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.